We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Regulator sat round table watching sky news or a shorter who knows how to play the game.
Ck never mentioned 50m tests, seriously this is the best they had on him? Insider dealing or something going on.
"With regards yesterday’s RNS, I am afraid this wasn’t something that the company or our NOMAD wanted to issue, we were forced to by the AIM regulatory. We tried to push back but they were insistent" Colin King
You are kidding me, so many issues that have been discussed with Aim over the years, and this is the time they have to speak up. They had nothing else? This is very suspicious.
I like the 'my current estimate is that we will commercialise over the summer months.' bit.
It is more or less confirmation that the test will be going to market.
Evening lads, know this is my first post but have been lurking in the shadows for a while on a few different stocks.
Just for clarity had an average of 52p yesterday which I sold for 75p on the fateful afternoon fall. Re bought at 67 this morning so happy with my holding overall and won't be budging.
Reason for the post I saw a user post an email from Colin King which being the sceptic I am looked a tad dodgy, so emailed him myself for verification, and lo and behold he replied:
Good afternoon Colin,
I hope this email finds you and the team well along with my great admiration for what you guys are doing over there.
I only had one question, an email reply from yourself has been posted online and I was just wondering if you be able to verify you sent it or someone is trying to mislead investors with it. I will post it below.
On Thu, May 28, 2020, 6:41 AM Colin King wrote:
No need to apologise for emailing me directly and I understand that you must be upset.
I think its fair to say we were all very annoyed with the regulator yesterday.
With regards yesterday’s RNS, I am afraid this wasn’t something that the company or our NOMAD wanted to issue, we were forced to by the AIM regulatory. We tried to push back but they were insistent
Their rationale was nothing that I had said, but the 50m tests referred to at the start of the interview by the interviewer. They felt that investors could have misinterpreted this that it was Omega and not the consortium that would be supplying that quantity of tests.
I was very deliberate in not disclosing anything that wasn’t already in the public domain and it was an opportunity that doesn’t come around every day to inform a wider community of the great work that the consortium is doing.
We will provide an update for both the Mologic ELISA test and the consortium self test as soon as we have something meaningful to say.
I have been avoiding giving out timelines before we achieved design freeze but confidentially we are happy with the progress that is being made and my current estimate is that we will commercialise over the summer months.
I hope that helps ease some of your concerns.
Best regards
Colin
From: xxxxxxx
Sent: 28 May 2020 00:25
To: Colin King
Subject: Today's ODX RNS update on stock exchange
Dear Colin,
Apologies for this direct email to you.
I'm a shareholder in ODX and really enjoyed your interview on Sky News and I have put some of my life savings in ODX as I believed ODX has massive potential for growth and doing its part in saving lives from the pandemic.
All the shareholders very happy to be invested until the RNS update that you provided at 4pm today. Many shareholders like me have lost money following that RNS update.
I agree that am the one to be blamed for putting money into ODX but I believed ODX can change my life fortune too,
Can't add the rest of original the email due to max characters but really reassuring to me, onwards and